JPWO2019199861A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019199861A5 JPWO2019199861A5 JP2021505184A JP2021505184A JPWO2019199861A5 JP WO2019199861 A5 JPWO2019199861 A5 JP WO2019199861A5 JP 2021505184 A JP2021505184 A JP 2021505184A JP 2021505184 A JP2021505184 A JP 2021505184A JP WO2019199861 A5 JPWO2019199861 A5 JP WO2019199861A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- cannabidiol
- formulated
- hemp extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 40
- 240000000218 Cannabis sativa Species 0.000 claims 34
- 235000009120 camo Nutrition 0.000 claims 34
- 235000005607 chanvre indien Nutrition 0.000 claims 34
- 239000011487 hemp Substances 0.000 claims 34
- 235000012765 hemp Nutrition 0.000 claims 34
- 235000012766 marijuana Nutrition 0.000 claims 34
- 239000002552 dosage form Substances 0.000 claims 26
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N Cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 20
- 229950011318 Cannabidiol Drugs 0.000 claims 20
- QHMBSVQNZZTUGM-MSOLQXFVSA-N Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-MSOLQXFVSA-N 0.000 claims 20
- CYQFCXCEBYINGO-ZYMOGRSISA-N (6aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-ZYMOGRSISA-N 0.000 claims 15
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 claims 14
- FQTLCLSUCSAZDY-QKXCFHHRSA-N Nerolidol Natural products CC(C)=CCC\C(C)=C/CC[C@](C)(O)C=C FQTLCLSUCSAZDY-QKXCFHHRSA-N 0.000 claims 14
- 239000000969 carrier Substances 0.000 claims 14
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 11
- QKPLRMLTKYXDST-NSEZLWDYSA-N (3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol;hydrochloride Chemical compound Cl.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O QKPLRMLTKYXDST-NSEZLWDYSA-N 0.000 claims 10
- 229920002907 Guar gum Polymers 0.000 claims 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 10
- 235000011187 glycerol Nutrition 0.000 claims 10
- 239000000665 guar gum Substances 0.000 claims 10
- 235000010417 guar gum Nutrition 0.000 claims 10
- 229960002154 guar gum Drugs 0.000 claims 10
- 230000001055 chewing Effects 0.000 claims 9
- 230000018984 mastication Effects 0.000 claims 9
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims 8
- NVEQFIOZRFFVFW-RGCMKSIDSA-N caryophyllene oxide Chemical compound C=C1CC[C@H]2O[C@]2(C)CC[C@H]2C(C)(C)C[C@@H]21 NVEQFIOZRFFVFW-RGCMKSIDSA-N 0.000 claims 8
- 235000021400 peanut butter Nutrition 0.000 claims 8
- QXACEHWTBCFNSA-SFQUDFHCSA-N Cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 7
- 239000003205 fragrance Substances 0.000 claims 7
- 229930004077 nerolidols Natural products 0.000 claims 7
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims 6
- IHPKGUQCSIINRJ-NTMALXAHSA-N (Z)-β-ocimene Natural products CC(C)=CC\C=C(\C)C=C IHPKGUQCSIINRJ-NTMALXAHSA-N 0.000 claims 6
- 244000215068 Acacia senegal Species 0.000 claims 6
- 229920000084 Gum arabic Polymers 0.000 claims 6
- 208000002193 Pain Diseases 0.000 claims 6
- 230000037165 Serum Concentration Effects 0.000 claims 6
- 229940005741 Sunflower lecithin Drugs 0.000 claims 6
- 235000010489 acacia gum Nutrition 0.000 claims 6
- 239000000205 acacia gum Substances 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 239000003921 oil Substances 0.000 claims 6
- 235000019198 oils Nutrition 0.000 claims 6
- 241000282326 Felis catus Species 0.000 claims 5
- 239000008169 grapeseed oil Substances 0.000 claims 5
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 claims 4
- NPNUFJAVOOONJE-ZIAGYGMSSA-N (-)-Isocaryophyllene Natural products C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 claims 4
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 claims 4
- NPNUFJAVOOONJE-GFUGXAQUSA-N (-)-β-caryophyllene Chemical compound C1CC(/C)=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-GFUGXAQUSA-N 0.000 claims 4
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 claims 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims 4
- TWVJWDMOZJXUID-SDDRHHMPSA-N 2-[(3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl]propan-2-ol Chemical compound C1([C@H](CC[C@H](C2)C(C)(C)O)C)=C2[C@@H](C)CC1 TWVJWDMOZJXUID-SDDRHHMPSA-N 0.000 claims 4
- YJISHJVIRFPGGN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy-6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 YJISHJVIRFPGGN-UHFFFAOYSA-N 0.000 claims 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims 4
- 240000003613 Ipomoea batatas Species 0.000 claims 4
- 235000002678 Ipomoea batatas Nutrition 0.000 claims 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N Myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims 4
- 240000009215 Nepeta cataria Species 0.000 claims 4
- 235000010679 Nepeta cataria Nutrition 0.000 claims 4
- 240000007594 Oryza sativa Species 0.000 claims 4
- 235000007164 Oryza sativa Nutrition 0.000 claims 4
- 229940100486 RICE STARCH Drugs 0.000 claims 4
- 229940075582 Sorbic Acid Drugs 0.000 claims 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 4
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims 4
- 229930001559 alpha-humulenes Natural products 0.000 claims 4
- 229930006725 alpha-pinene Natural products 0.000 claims 4
- 229930006719 beta-myrcene Natural products 0.000 claims 4
- 229930006722 beta-pinene Natural products 0.000 claims 4
- TWVJWDMOZJXUID-QJPTWQEYSA-N guaiol Natural products OC(C)(C)[C@H]1CC=2[C@H](C)CCC=2[C@@H](C)CC1 TWVJWDMOZJXUID-QJPTWQEYSA-N 0.000 claims 4
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 claims 4
- 229930007744 linalool Natural products 0.000 claims 4
- 235000013379 molasses Nutrition 0.000 claims 4
- 229920001592 potato starch Polymers 0.000 claims 4
- 235000009566 rice Nutrition 0.000 claims 4
- WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 claims 4
- 235000010199 sorbic acid Nutrition 0.000 claims 4
- 239000004334 sorbic acid Substances 0.000 claims 4
- FAMPSKZZVDUYOS-KXWHQPPKSA-N α-Humulene Chemical compound C\C1=C\CC(C)(C)\C=C/C\C(C)=C/CC1 FAMPSKZZVDUYOS-KXWHQPPKSA-N 0.000 claims 4
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 3
- KXKPYJOVDUMHGS-OSRGNVMNSA-N Chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 claims 3
- 229930006739 camphene Natural products 0.000 claims 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims 3
- 239000000796 flavoring agent Substances 0.000 claims 3
- 235000013355 food flavoring agent Nutrition 0.000 claims 3
- 229920002674 hyaluronan Polymers 0.000 claims 3
- 229960003160 hyaluronic acid Drugs 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000000843 powder Substances 0.000 claims 3
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 3
- 229930007924 β-ocimene Natural products 0.000 claims 3
- CRPUJAZIXJMDBK-DTWKUNHWSA-N (+)-camphene Chemical compound C1C[C@@H]2C(=C)C(C)(C)[C@H]1C2 CRPUJAZIXJMDBK-DTWKUNHWSA-N 0.000 claims 2
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 claims 2
- 208000005298 Acute Pain Diseases 0.000 claims 2
- 208000006820 Arthralgia Diseases 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 2
- 241000282465 Canis Species 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 2
- 235000002566 Capsicum Nutrition 0.000 claims 2
- 241000283073 Equus caballus Species 0.000 claims 2
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 claims 2
- 235000010705 Eucalyptus maculata Nutrition 0.000 claims 2
- 235000009683 Eucalyptus polybractea Nutrition 0.000 claims 2
- 235000009687 Eucalyptus sargentii Nutrition 0.000 claims 2
- 241000287828 Gallus gallus Species 0.000 claims 2
- 210000004185 Liver Anatomy 0.000 claims 2
- ZDKZHVNKFOXMND-NBEYISGCSA-N Nepetalactone Chemical compound O=C1OC=C(C)[C@@H]2[C@H]1[C@@H](C)CC2 ZDKZHVNKFOXMND-NBEYISGCSA-N 0.000 claims 2
- 239000006002 Pepper Substances 0.000 claims 2
- 235000016761 Piper aduncum Nutrition 0.000 claims 2
- 235000017804 Piper guineense Nutrition 0.000 claims 2
- 240000000129 Piper nigrum Species 0.000 claims 2
- 235000008184 Piper nigrum Nutrition 0.000 claims 2
- 208000004550 Postoperative Pain Diseases 0.000 claims 2
- 208000000399 Procedural Pain Diseases 0.000 claims 2
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 claims 2
- 229940081969 Saccharomyces cerevisiae Drugs 0.000 claims 2
- 241000282898 Sus scrofa Species 0.000 claims 2
- 229960003080 Taurine Drugs 0.000 claims 2
- 208000004371 Toothache Diseases 0.000 claims 2
- 125000003447 alpha-pinene group Chemical group 0.000 claims 2
- 239000003240 coconut oil Substances 0.000 claims 2
- 235000019864 coconut oil Nutrition 0.000 claims 2
- 238000000641 cold extrusion Methods 0.000 claims 2
- 235000001612 eucalyptus Nutrition 0.000 claims 2
- 235000001617 eucalyptus Nutrition 0.000 claims 2
- 235000001621 eucalyptus Nutrition 0.000 claims 2
- 235000006356 eucalyptus Nutrition 0.000 claims 2
- 235000021323 fish oil Nutrition 0.000 claims 2
- 229940095045 isopulegol Drugs 0.000 claims 2
- 235000021388 linseed oil Nutrition 0.000 claims 2
- 239000000944 linseed oil Substances 0.000 claims 2
- 239000004006 olive oil Substances 0.000 claims 2
- 235000008390 olive oil Nutrition 0.000 claims 2
- 235000005227 red mallee Nutrition 0.000 claims 2
- 229940119224 salmon oil Drugs 0.000 claims 2
- 239000008159 sesame oil Substances 0.000 claims 2
- 235000011803 sesame oil Nutrition 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 206010003246 Arthritis Diseases 0.000 claims 1
- 240000001200 Eucalyptus globulus Species 0.000 claims 1
- 240000000437 Eucalyptus leucoxylon Species 0.000 claims 1
- 206010072575 Gingival inflammation Diseases 0.000 claims 1
- 206010018286 Gingival pain Diseases 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 230000002917 arthritic Effects 0.000 claims 1
- 235000015241 bacon Nutrition 0.000 claims 1
- 235000014121 butter Nutrition 0.000 claims 1
- 125000002382 camphene group Chemical group 0.000 claims 1
- 229930003827 cannabinoid Natural products 0.000 claims 1
- 239000003557 cannabinoid Substances 0.000 claims 1
- 230000002149 cannabinoid Effects 0.000 claims 1
- 229940065144 cannabinoids Drugs 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000006199 nebulizer Substances 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 235000013594 poultry meat Nutrition 0.000 claims 1
- 230000000506 psychotropic Effects 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
- -1 δ-limonene Natural products 0.000 claims 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2024045083A JP2024083365A (ja) | 2018-04-09 | 2024-03-21 | 動物における疼痛の処置のためのアサ抽出物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862655170P | 2018-04-09 | 2018-04-09 | |
US62/655,170 | 2018-04-09 | ||
PCT/US2019/026631 WO2019199861A2 (en) | 2018-04-09 | 2019-04-09 | Hemp extract for treatment of pain in animals |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024045083A Division JP2024083365A (ja) | 2018-04-09 | 2024-03-21 | 動物における疼痛の処置のためのアサ抽出物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021521277A JP2021521277A (ja) | 2021-08-26 |
JPWO2019199861A5 true JPWO2019199861A5 (pt) | 2022-04-21 |
Family
ID=68163314
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021505184A Pending JP2021521277A (ja) | 2018-04-09 | 2019-04-09 | 動物における疼痛の処置のためのアサ抽出物 |
JP2024045083A Pending JP2024083365A (ja) | 2018-04-09 | 2024-03-21 | 動物における疼痛の処置のためのアサ抽出物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024045083A Pending JP2024083365A (ja) | 2018-04-09 | 2024-03-21 | 動物における疼痛の処置のためのアサ抽出物 |
Country Status (11)
Country | Link |
---|---|
US (2) | US20230110830A1 (pt) |
EP (1) | EP3773528B1 (pt) |
JP (2) | JP2021521277A (pt) |
CN (1) | CN112969452A (pt) |
AU (1) | AU2019251357B2 (pt) |
BR (1) | BR112020020850A2 (pt) |
CA (1) | CA3096842A1 (pt) |
ES (1) | ES2973731T3 (pt) |
MX (1) | MX2020010603A (pt) |
SG (1) | SG11202010006UA (pt) |
WO (1) | WO2019199861A2 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019299213A1 (en) * | 2018-07-02 | 2021-02-11 | Companion Sciences, Llc | Cannabidiol combination compositions |
US11484487B1 (en) * | 2018-07-23 | 2022-11-01 | Robell Research, Inc. | Gingivitis gum serum |
CN114727970A (zh) * | 2019-07-02 | 2022-07-08 | 艾乐文特科学公司 | 用于治疗动物中的疼痛、癌症和癫痫的大麻提取物 |
CN111956664A (zh) * | 2019-12-03 | 2020-11-20 | 云南汉盟制药有限公司 | 一种宠物用组合物及其应用 |
AU2020412501A1 (en) * | 2019-12-24 | 2022-08-18 | Cannadol Pharmaceuticals Ltd | Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety |
AU2021227227A1 (en) * | 2020-02-25 | 2022-10-13 | The Queen's Medical Center | Cannabinoid compositions |
AU2021268900A1 (en) * | 2020-05-04 | 2023-01-05 | Agronomed Management, Llc | Topical anti-inflammatory cannabinoid compositions |
AU2021215262B2 (en) * | 2020-06-12 | 2023-12-14 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating chronic pain |
US20220110888A1 (en) * | 2020-10-09 | 2022-04-14 | Charlotte's Web, Inc. | Composition for the treatment of psoriasis |
WO2023130161A1 (en) * | 2022-01-10 | 2023-07-13 | Dolce Cann Global Pty Ltd | Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda) along with an additional active agent |
WO2023130160A1 (en) * | 2022-01-10 | 2023-07-13 | Dolce Cann Global Pty Ltd | Compositions and methods for treating non-neurological disorders with combination products comprising a cannabinoid mixture rich in cannabidiolic acid (cbda). |
WO2023173060A1 (en) * | 2022-03-10 | 2023-09-14 | Portland Technology Holdings Llc | Compositions comprising hemp extract and related treatment methods |
WO2024082014A1 (en) * | 2022-10-21 | 2024-04-25 | Dolce Cann Global Pty Ltd | Compositions comprising cannabidiolic acid and fatty acids |
KR102524364B1 (ko) * | 2022-10-24 | 2023-04-24 | 전북대학교산학협력단 | 칸나비디올 및 타우린을 포함하는 치주염 예방 또는 치료용 조성물 |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10051427C1 (de) | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
US8034843B2 (en) | 2002-02-01 | 2011-10-11 | Gw Pharma Limited | Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
GB0222077D0 (en) | 2002-09-23 | 2002-10-30 | Gw Pharma Ltd | Methods of preparing cannabinoids from plant material |
EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
CN1840051B (zh) * | 2006-01-23 | 2013-08-28 | 北京因科瑞斯生物制品研究所 | 一种麝香祛痛凝胶及其制备方法 |
US8481085B2 (en) | 2006-06-15 | 2013-07-09 | Gw Pharma Limited | Pharmaceutical compositions comprising cannabigerol |
GB2448535A (en) | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
GB2450493A (en) | 2007-06-25 | 2008-12-31 | Gw Pharma Ltd | Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors |
DE602007011766D1 (de) | 2007-10-02 | 2011-02-17 | Vivacell Biotechnology Espana S L | Zusammensetzung mit nicht-psychotropen Cannabinoiden zur Behandlung von Entzündungserkrankungen |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
NL2006621C2 (en) * | 2011-04-18 | 2012-10-22 | Fytagoras B V | New medical use for acidic cannabinoids. |
US8758826B2 (en) | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
JP2014534178A (ja) | 2011-09-30 | 2014-12-18 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC | 癌の処置方法 |
US9254272B2 (en) | 2011-11-30 | 2016-02-09 | Sutter West Bay Hospitals | Resorcinol derivatives |
WO2013147965A1 (en) * | 2012-03-28 | 2013-10-03 | Freeman Keith Gerald | Medical compositions, methods of making and using those compositions, and kits including those compositions |
US20140256692A1 (en) * | 2013-03-07 | 2014-09-11 | Nicholas Adam Brockman | Composition and Method for Alleviation of Pain and Inflammation |
GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
WO2015025312A1 (en) * | 2013-08-21 | 2015-02-26 | Cannabics Pharmaceuticals Inc | Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |
AU2014347807A1 (en) * | 2013-10-31 | 2016-05-26 | Full Spectrum Laboratories, Ltd. | Terpene and cannabinoid formulations |
WO2015069763A2 (en) | 2013-11-05 | 2015-05-14 | First Watersign Llc | Sublingual cannabis dosage form and methods of making and using the same |
GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
US20160000843A1 (en) | 2014-07-01 | 2016-01-07 | MJAR Holdings, LLC | High cannabidiol cannabis strains |
US9394510B2 (en) | 2014-08-25 | 2016-07-19 | Full Spectrum Laboratories Limited | Apparatus and methods for the simultaneous production of compounds |
CA2965493C (en) * | 2014-10-21 | 2021-12-07 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
WO2016087649A2 (en) | 2014-12-04 | 2016-06-09 | Servicio Andaluz De Salud | Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues |
MX2017007550A (es) * | 2014-12-12 | 2018-05-04 | Ojai Energetics Pbc | Composiciones microencapsuladas de cannabinoides. |
MX2017009846A (es) | 2015-01-31 | 2018-04-11 | Constance Therapeutics Inc | Metodos para la preparacion de extractos y composiciones de aceite de cannabis. |
AU2016215094B2 (en) * | 2015-02-05 | 2019-09-26 | Colorado Can Llc | Purified CBD and CBDA, and methods, compositions and products employing CBD or CBDA |
ES2860452T3 (es) | 2015-02-16 | 2021-10-05 | Apirx Pharmaceutical Usa Llc | Composiciones cosméticas y tópicas que comprenden cannabigerol y cannabidiol |
US20170266153A1 (en) | 2015-02-27 | 2017-09-21 | Ebbu, LLC | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
WO2016141056A1 (en) * | 2015-03-02 | 2016-09-09 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoids |
AU2016261707A1 (en) | 2015-05-13 | 2017-12-07 | One World Cannabis Ltd | Use of cannabis to treat fibromyalgia, methods and compositions thereof |
EP3302033A4 (en) | 2015-05-28 | 2018-10-31 | Tweed Inc. | Cannabis plants having modified expression of thca synthase |
KR102460440B1 (ko) * | 2015-07-22 | 2022-10-28 | 피토파마 인터내셔널 리미티드 | 꿀벌―섭취가능한 조성물, 이를 이용한 꿀 생산 방법 및 이에 의해 생산된 꿀 |
US10064950B2 (en) | 2015-07-24 | 2018-09-04 | Shabana Naheed | Medication dispensing system |
GB2541191A (en) | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
GB2542797A (en) | 2015-09-29 | 2017-04-05 | Gw Pharma Ltd | Use of cannabinoids in the treatment of inflammatory skin diseases |
CA3006182A1 (en) * | 2015-11-24 | 2017-06-01 | Constance Therapeutics, Inc. | Cannabis oil compositions and methods for preparation thereof |
US9956173B1 (en) | 2016-02-08 | 2018-05-01 | Jeff Nordahl | Packaged frozen cubes of cannabis juice purée that are non-psychoactive |
GB2549277B (en) | 2016-04-11 | 2021-02-17 | Gw Res Ltd | Cannabidiolic Acid for use in the Treatment of Autism Spectrum Disorder |
US10265362B2 (en) | 2016-04-12 | 2019-04-23 | Scott Schaneville | Ingestible films having substances from hemp or cannabis |
MX2018012448A (es) | 2016-04-12 | 2019-07-08 | Habi Pharma Pty Ltd | Preparacion liposomal y metodos de tratamiento. |
LT6486B (lt) * | 2016-04-13 | 2018-01-10 | UAB "SatiMed" | Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui |
CN106074465A (zh) * | 2016-06-14 | 2016-11-09 | 云南瑞酚生物科技有限公司 | 大麻酚类化合物在制备治疗痛风性关节炎药物中的应用 |
IL246790A0 (en) | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
KR20220132674A (ko) * | 2016-08-03 | 2022-09-30 | 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 | 카나비스 조성물 |
BR112019003815A2 (pt) | 2016-08-29 | 2019-05-21 | Canopy Growth Corporation | composições solúveis em água compreendendo canabinoides purificados |
EP4364593A2 (en) | 2016-09-14 | 2024-05-08 | Altria Client Services LLC | Smoking device |
IL248149B (en) * | 2016-09-29 | 2020-03-31 | Garti Nissim | Formulations of dilutable cannabinoids and processes for their preparation |
EP3571307A1 (en) * | 2017-01-14 | 2019-11-27 | Herbolea Biotech S.R.L. | Enzyme-assisted lipid-based extraction and stabilization of phyto-cannabinoids and terpens and products obtained thereof |
JP2020513805A (ja) | 2017-03-18 | 2020-05-21 | マクガラー,スティーブン,エム. | カンナビジオール酸を含むペットフード |
US20200093785A1 (en) | 2017-03-24 | 2020-03-26 | Deidra Stauff | Skin care compositions and methods |
EP3599831A4 (en) | 2017-04-05 | 2020-12-09 | University Of Mississippi | ISOLATION OF PURE CANNABINOIDS FROM CANNABIS |
AU2018266262B2 (en) | 2017-05-08 | 2022-10-06 | Inmed Pharmaceuticals Inc. | Ocular drug delivery formulation |
CA3064563A1 (en) | 2017-05-22 | 2018-11-29 | Gbs Global Biopharma, Inc. | Myrcene-containing complex mixtures targeting trpv1 |
WO2019003163A2 (en) | 2017-06-28 | 2019-01-03 | Buzzelet Development And Technologies Ltd. | CANNABINOID PRODUCT ENRICHED IN TERPENE GOOD FOR WOMEN'S HEALTH |
DE18837223T1 (de) | 2017-07-26 | 2020-03-26 | Tgx Soft Chew, Llc | Stärkefreier weicher kausnack für veterinärmedizinische anwendungen |
US10597348B1 (en) | 2017-08-21 | 2020-03-24 | Jeff Nordahl | Infusing raw cannabinoids into food oil |
US10272051B2 (en) | 2017-08-28 | 2019-04-30 | Axim Biotechnologies, Inc. | Method to treat atopic dermatitis |
US11484510B2 (en) | 2017-08-28 | 2022-11-01 | Apirx Pharmaceutical Usa, Llc | Method to treat vitiligo |
US20190060250A1 (en) | 2017-08-28 | 2019-02-28 | Axim Biotechnologies, Inc. | Method to treat psoriasis |
EP3449992A1 (en) | 2017-09-04 | 2019-03-06 | Bionorica Ethics GmbH | Recovery of acidic cannabinoids from plant material |
IL272709B1 (en) | 2017-09-08 | 2024-05-01 | Scicann Therapeutics Inc | The compounds containing cannabinoid and spilantol |
US10654823B2 (en) | 2017-09-09 | 2020-05-19 | Scientific Holdings, Llc | Transparent glassy cannabinoid compositions |
WO2019070876A2 (en) | 2017-10-03 | 2019-04-11 | The Regents Of The University Of Colorado | METHOD FOR DIFFERENTIATING CANNABIS PLANT CULTIVARS BASED ON CANNABINOID SYNTHASE PARALOGUES |
WO2019071302A1 (en) | 2017-10-09 | 2019-04-18 | The University Of Sydney | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES |
WO2019104442A1 (en) | 2017-11-30 | 2019-06-06 | Canopy Growth Corporation | Liquid dosage forms, methods of making and use |
US20200405685A1 (en) | 2017-12-08 | 2020-12-31 | Biotech Institute, Llc | High cannabigerol cannabis plants, methods of producing and methods of using them |
AU2019221321A1 (en) | 2018-02-15 | 2020-10-01 | Syqe Medical Ltd. | Method and inhaler for providing two or more substances by inhalation |
WO2019159176A1 (en) | 2018-02-18 | 2019-08-22 | Scicann Therapeutics Inc. | Compositions and methods for treatment of neurodegenerative diseases |
US20190297821A1 (en) | 2018-03-28 | 2019-10-03 | Jack Hempicine Llc | Cross-hybridization of distinct homozygous cannabis plants to produce consistent early flowering seeds |
WO2019195752A1 (en) | 2018-04-05 | 2019-10-10 | Canopy Holdings, LLC | Hemp powder |
WO2019210401A1 (en) | 2018-05-01 | 2019-11-07 | Willinsky Michael | Novel anti-inflammatory, analgesic, anti-depressant cannabinoid and methods related to manufacture of same |
WO2019227167A1 (en) | 2018-06-01 | 2019-12-05 | The University Of Sydney | Compositions and treatments |
CA3048539A1 (en) | 2018-07-03 | 2020-01-03 | Virgil Macaluso | Methods of heating cannabis plant material |
US20200288659A1 (en) | 2018-07-12 | 2020-09-17 | Jack Hempicine Llc | Production of cannabis plants and seeds using a targeted allele |
US20200015440A1 (en) | 2018-07-12 | 2020-01-16 | Jack Hempicine Llc | Production of cannabis plants and seeds using a targeted allele |
US20200015441A1 (en) | 2018-07-12 | 2020-01-16 | Jack Hempicine Llc | Production of cannabis plants and seeds using a targeted allele |
IL279824B2 (en) | 2018-07-19 | 2023-10-01 | Al& Am Pharmachem Ltd | A process for the separation and purification of tetrahydrocannabinolic acid and cannabidiol acid from plant extracts |
US20200038305A1 (en) | 2018-08-02 | 2020-02-06 | Divios LLC | Sunscreen or Sunblock Composition |
EP3843763A4 (en) | 2018-08-27 | 2022-06-15 | Emerald Health Therapeutics Canada Inc. | IMPROVED CANNABINOID BIOAVAILABILITY |
US20210205236A1 (en) | 2018-08-27 | 2021-07-08 | Emerald Health Therapeutics Canada Inc. | Therapeutic combinations of boswellia extract and cannabinoids |
MX2021002719A (es) | 2018-09-05 | 2021-09-23 | Nemus Bioscience Inc | Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos. |
WO2020081108A1 (en) | 2018-10-18 | 2020-04-23 | Taba Ip, Llc | Purification of cannabinoids from crude cannabis oil |
WO2020084427A1 (en) | 2018-10-23 | 2020-04-30 | Radient Technologies Innovations Inc. | Temperature control for active compound extraction |
WO2020123383A1 (en) | 2018-12-10 | 2020-06-18 | Natural Extraction Systems, LLC | Compositions with novel cannabinoid and terpene profiles |
US20220040144A1 (en) | 2018-12-12 | 2022-02-10 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization | Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl) |
WO2020165902A1 (en) | 2019-02-15 | 2020-08-20 | Plantbiosis Ltd. | Method for synthesis of cannabis products |
NL2022616B1 (en) | 2019-02-21 | 2020-09-18 | Patrick Alexander Unger | Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia |
-
2019
- 2019-04-09 US US17/045,945 patent/US20230110830A1/en active Pending
- 2019-04-09 CA CA3096842A patent/CA3096842A1/en active Pending
- 2019-04-09 EP EP19785569.5A patent/EP3773528B1/en active Active
- 2019-04-09 BR BR112020020850-7A patent/BR112020020850A2/pt unknown
- 2019-04-09 ES ES19785569T patent/ES2973731T3/es active Active
- 2019-04-09 SG SG11202010006UA patent/SG11202010006UA/en unknown
- 2019-04-09 JP JP2021505184A patent/JP2021521277A/ja active Pending
- 2019-04-09 MX MX2020010603A patent/MX2020010603A/es unknown
- 2019-04-09 WO PCT/US2019/026631 patent/WO2019199861A2/en unknown
- 2019-04-09 CN CN201980037388.3A patent/CN112969452A/zh active Pending
- 2019-04-09 AU AU2019251357A patent/AU2019251357B2/en active Active
-
2022
- 2022-03-01 US US17/684,154 patent/US11712456B2/en active Active
-
2024
- 2024-03-21 JP JP2024045083A patent/JP2024083365A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3773528B1 (en) | Hemp extract for treatment of pain in animals | |
US20120225053A1 (en) | Compositions and methods for the prevention and treatment of conditions associated with inflamation | |
US20110086119A1 (en) | Preparation for the relief of disease | |
JPWO2019199861A5 (pt) | ||
CN1927160A (zh) | 漱口液及制备方法 | |
AU2001295769A1 (en) | A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade | |
WO2004028549A1 (fr) | Capsules de coixenolide destinees au traitement d'une maladie prostatique | |
JP2007297370A (ja) | 血糖値上昇抑制剤 | |
WO2007116980A1 (ja) | 血糖値上昇抑制剤 | |
WO2021150595A1 (en) | Novel formulations comprising cannabis | |
JP2001048802A (ja) | 糖尿病に有効な健康補助食品およびその使用方法、並びに糖尿病に有効な食品配合剤 | |
JP7162357B2 (ja) | 桂皮酸誘導体の吸収促進剤 | |
US20110118243A1 (en) | Anti-inflammatory drug delivery system | |
US20230056488A1 (en) | Composition, article and method for affecting a mammal | |
WO2008075649A1 (ja) | 発毛促進用飲食物、医薬部外品、医薬組成物ならびに発毛促進方法 | |
CN106163510A (zh) | 褪黑素分泌调节剂、褪黑素分泌调节方法 | |
US20230404942A1 (en) | Life Extension and Quality of Life Improvement for Humans | |
JP4415063B1 (ja) | 脂肪低減剤 | |
JP4469406B1 (ja) | 血中コレステロール低下剤 | |
EP3919050A1 (en) | Nutraceutic composition containing limonene and a dry extract of cocoa fibre for the treatment of obesity | |
KR20210023872A (ko) | Rls 치료를 위한 님 | |
CA3196828A1 (fr) | Nouvelle composition therapeutique a base d'huiles essentielles a faibles doses | |
CN116940343A (zh) | 关节炎和银屑病的补充剂 | |
CN105832970A (zh) | 蜂胶薄荷酊及其制备方法 | |
JP2008174536A (ja) | 発毛促進用飲食物、医薬部外品、医薬組成物ならびに発毛促進方法 |